Nestle Health Science announces appointment of Mario Lepinat as the business executive officer for Germany and Austria

Sample article from our Food & Beverage

GRAZ, Austria , February 6, 2024 (press release) –

Mario Lepinat has been appointed as the new Business Executive Officer for Germany and Austria at Nestlé Health Science. He replaces Ingo Jurk , who has been appointed as the Business Executive Officer for European Cluster Markets. Lepinat has extensive experience in marketing and sales roles in the Fast Moving Consumer Goods and Medical Nutrition & Consumer Care sectors. He joined Nestlé Health Science in 2019 and has played a significant role in the successful development of the company in Germany and Austria . Nestlé Health Science, founded in 2011, focuses on providing nutrition therapies and nutrients for all age groups through research and development.

Key Highlights:

* Mario Lepinat previously led the Consumer Care business of Nestlé Health Science

* The company emphasizes research and development to offer innovative solutions

Original Press Release:

Graz , Feb. 5 -- Nestle issued the following news release:

Nestlé Health Science: Mario Lepinat takes on the role of Business Executive Officer for Germany and Austria . He succeeds Ingo Jurk , who was appointed Business Executive Officer European Cluster Markets.

Mario Lepinat most recently headed Nestlé Health Science's consumer care business as business unit head and at the same time worked as managing director for Promedico, which develops and is responsible for the sales and marketing strategies of a wide range of health products. On January 15, 2024 , he took over the role of Business Executive Officer of NHSc.

Lepinat has many years of experience in marketing and sales functions in the areas of Fast Moving Consumer Goods and Medical Nutrition & Consumer Care and has already held various DA-CH roles in the past. He has been working at Nestlé Health Science since 2019 and has played a key role in the company's successful development in Germany and Austria . Since the acquisition of Promedico by NHSc in 2022, he has successfully led the integration of Promedico into Nestlé Health Science. He drove market expansion in the areas of VMHS (Vitamins, Minerals, Herbal and Supplements) and Active Nutrition and successfully introduced the Solgar brand in Germany and Austria . In addition, he brought the market development of Pure Encapsulations® further on a growth path. Reinhard Wagner will succeed him in his position as Managing Director of the Consumer Care Business Unit (Promedico).

About Nestlé Health Science

Founded in 2011, Nestlé Health Science is built on a strong foundation of decades of innovation in nutritional sciences. Since then, the company has evolved significantly and strengthened its commitment to healthier living. It offers needs-based nutritional therapies and nutrients for newborns to seniors. To achieve this, science is needed above all. Through extensive research and development and collaboration with healthcare providers, the latest findings can be offered in the form of innovations.

Disclaimer: The Above Content is Auto-Translated

[Category: Health Care, Management Changes]

Source: Nestle

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Dan Rivard
Dan Rivard
- VP Market Development -

We offer built-to-order food & beverage coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.